
Cardio Diagnostics fell 33.2% from $2.56 to $1.71, behind the S&P 500's +10.2%. Its worst day was Mar 13 (−38.6%), and its low came Feb 5 at $1.05.
Nov 19, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Cardio Diagnostics shares rose 24.2%, while the S&P 500 rose 1.5%.
+24.2% · S&P 500 +1.5%
Cardio Diagnostics closed at its lowest level of the year, 59.0% below where the year started.
−13.9% · S&P 500 −1.2%
Story events cover the past 12 months · Times ET
Cardio Diagnostics shares rose 79.0%, while the S&P 500 rose 0.5%.
+79.0%, the year's best day · S&P 500 +0.5%
Cardio Diagnostics closed at its highest level of the year, 155.9% above where the year started.
+25.5% · S&P 500 −0.5%
EPS of $-0.80 was reported on $3,555.00 revenue.
−13.9% · S&P 500 +1.0%
EPS of $-0.63 was reported on $2,680.00 revenue.
−10.3% · S&P 500 −0.1%
EPS of $-0.51 was reported on $5,360.00 revenue.
−3.9% · S&P 500 0.0%
Where it ended: a close of $1.71 on Nov 17, 2026. Up next: Q3 2026 earnings on Dec 1, 2026.
Nothing in the past 12 months.
All CDIO analyst actionsNothing in the past 12 months.
All CDIO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CDIO and SPY from Benzinga historical bars. Not investment advice.